EMA addresses considerations for single-arm trials
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/Policy